Partner Adam Finerman and Associates Jennifer Dare, Sean Cheatle and Maryana Curci counseled life sciences company Enzo Biochem in its entry into an Agreement and Plan of Merger to be acquired by Battery Ventures, a global, technology-focused investment firm, through its newly formed entity Bethpage Parent, Inc. Under the terms of the Merger Agreement, Battery will acquire Enzo for $0.70 per share in cash, representing a total consideration of approximately $37 million.
The transaction is expected to close in the third quarter of 2025.
